In this study, we observed that inhibition of miR-203 in ER-positive breast cancer cells suppresses cell proliferation by inhibiting cyclin D1 and pStat3, and inhibits tumor growth in a breast cancer preclinical model. The gene discussed is CCND1; the disease is breast carcinoma.